Exact Sciences Corporation EXAS NASDAQ

Exact Sciences Corporation (EXAS) has a negative trailing P/E of -95.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 582.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.04%, forward earnings yield 0.17%. PEG 5.59.

Criteria proven by this page:

• VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -95.7); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -1.04%); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 5.59).
• Forward P/E 582.8 — analysts expect a return to profitability with estimated EPS of $0.18 for FY2026.
• PEG Ratio 5.59 — above 2.0 suggests expensive relative to earnings growth.
• Trailing Earnings Yield -1.04% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.17% as earnings recover.
• Analyst consensus target $103.18 (-1.6% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 36/100 with 1/7 criteria passed.